Time Restricted Eating for POTS
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores time-restricted eating (TRE) as a potential treatment for Postural Orthostatic Tachycardia Syndrome (POTS), a condition causing fatigue, dizziness, and rapid heartbeat when standing. Researchers aim to determine if limiting eating to an 8-10 hour window each day can improve symptoms by addressing energy use and balance issues linked to mitochondrial health, the energy producers within cells. Individuals who have experienced POTS symptoms for over six months and currently have longer daily eating periods may be suitable for the trial. Participants will use a smartphone app to track their caloric intake. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could lead to new insights and treatments for POTS.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you cannot participate if you are currently taking medications that affect appetite or if you have had recent changes in thyroid medication.
What prior data suggests that time-restricted eating is safe for POTS patients?
Research has shown that time-restricted eating (TRE), where eating occurs only during an 8- to 10-hour period each day, can improve life quality and heart health in people with POTS. Studies have found that this eating pattern can reduce inflammation and enhance the immune and nervous systems. Participants in these studies reported feeling better overall.
However, not all results are positive. One study found a connection between an 8-hour TRE schedule and a higher risk of death from heart disease, suggesting TRE might not be safe for everyone, especially those with heart issues.
Overall, many people seem to handle TRE well, with some benefits for those with POTS. As always, consulting a healthcare provider before starting any new eating plan is important.12345Why are researchers excited about this trial?
Time restricted eating is unique because it offers a non-pharmaceutical approach to managing Postural Orthostatic Tachycardia Syndrome (POTS). Unlike current treatments that often involve medications like beta-blockers or lifestyle changes focused on increased fluid and salt intake, this method involves limiting food consumption to an 8-10-hour window each day. Researchers are excited about this approach because it could help regulate blood volume and autonomic function in a natural way, potentially reducing symptoms without the side effects associated with medications. Additionally, using a smartphone app to log caloric intake allows for personalized monitoring and adherence, making it easier for patients to manage their condition.
What evidence suggests that time-restricted eating might be an effective treatment for POTS?
Research shows that time-restricted eating (TRE), where eating occurs only during an 8-10 hour period each day, may help people with postural orthostatic tachycardia syndrome (POTS). In this trial, all participants will follow a TRE regimen. Studies have found that TRE can improve quality of life and heart rate. It also helps lower inflammation and strengthens the immune system. Researchers believe TRE improves mitochondrial health, enhancing energy production in cells. This boost in energy use and immune function could help manage POTS symptoms like tiredness and lightheadedness.12346
Who Is on the Research Team?
Taylor Doherty, MD
Principal Investigator
Professor of Medicine
Pam Taub, MD
Principal Investigator
Professor of Medicine
Are You a Good Fit for This Trial?
This trial is for adults aged 18-70 with Postural Orthostatic Tachycardia Syndrome (POTS), who experience rapid heartbeat upon standing, have a BMI under 40, and eat over a 12-hour period daily. Excluded are those with diabetes, inflammatory diseases, recent major heart events or eating disorders, pregnant or breastfeeding women, and individuals on certain diets or medications affecting appetite.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants implement a daily 8-10-hour window for caloric intake using time-restricted eating (TRE) for 12 weeks
Follow-up
Participants are monitored for changes in mitochondrial function and immune response
What Are the Treatments Tested in This Trial?
Interventions
- Time restricted eating
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor
Dysautonomia International
Collaborator